• 01Company
    Company overview
    Meet our management
    Partnering
    Pipeline
  • 02Products
  • 03Patient support
  • 04Pharmacovigilance
Newsroom
Join us
Contact us
Media
NewsroomJoin usContact usMedia
ProductsPatient supportPharmacovigilance
Company overview
Meet our management
Partnering
Pipeline

Newsroom

  • Business
    05 September 2022

    Almatica team attends Psych Congress

    Almatica Clinical R&D team attends Psych Congress, Sept 17-20 to Present Loreev XR PK, Food Effect & Sprinkle Study Posters.

  • Business
    08 June 2022

    Almatica announces third SNRI/SSRI branded CNS product launch this year

  • Business
    01 May 2022

    Citalopram 30mg Capsule approved by FDA

  • Business
    07 March 2022

    Loreev XR (lorazepam) now available in 1.5 mg dose

  • Business
    08 November 2021

    Almatica receives FDA approval for Sertraline HCL

  • Business
    27 August 2021

    Loreev XR (lorazepam): New Extended-Release Lorazepam Approved By FDA

  • Business

    A Longer Acting Lorazepam

  • Company overview
  • Meet our management
  • Product catalog
  • Partnering
  • Patient support
  • Careers
  • Pharmacovigilance
  • Contact us
  • Media Gallery
  • Terms of use
  • Privacy policy

© 2022 Almatica Pharma LLC. All rights reserved. ALM-WWW-003A